Variable | Age | p value | |||
---|---|---|---|---|---|
18–25 | 26–35 | 36–45 | 46–55 | ||
N (%) | N (%) | N (%) | N (%) | ||
Gender | Â | Â | Â | Â | Â |
 Women | 3904 (94.0%) | 6537 (96.8%) | 6443 (97.8%) | 1822 (97.8%) | < 0.001 |
 Non-binary/other | 251 (6.0%) | 216 (3.2%) | 144 (2.2%) | 41 (2.2%) |  |
Trans | Â | Â | Â | Â | Â |
 Yes | 107 (2.6%) | 38 (0.6%) | 10 (0.2%) | 3 (0.2%) | < 0.001 |
 No | 3986 (95.9%) | 6663 (98.7%) | 6553 (99.5%) | 1853 (99.5%) |  |
 Don’t know | 62 (1.5%) | 52 (0.8%) | 24 (0.4%) | 7 (0.4%) |  |
Country of birth | Â | Â | Â | Â | Â |
 Spain | 3859 (94.4%) | 6232 (93.6%) | 5988 (92.8%) | 1666 (92.0%) | 0.001 |
 Other | 231 (5.6%) | 423 (6.4%) | 466 (7.2%) | 144 (8.0%) |  |
Administrative situation | Â | Â | Â | Â | Â |
 Spanish nationality | 3989 (96.3%) | 6428 (95.5%) | 6294 (95.8%) | 1781 (96.0%) | < 0.001 |
 Permanent residency | 102 (2.5%) | 209 (3.1%) | 241 (3.7%) | 67 (3.6%) |  |
 Temporal residency | 42 (1.0%) | 79 (1.2%) | 19 (0.3%) | 5 (0.3%) |  |
 No permit/in process | 9 (0.2%) | 17 (0.3%) | 15 (0.2%) | 2 (0.1%) |  |
Employment situation | Â | Â | Â | Â | Â |
 Working full-time/part-time | 1319 (31.7%) | 5014 (74.2%) | 4811 (73.0%) | 1430 (76.8%) | < 0.001 |
 Self-employed | 70 (1.7%) | 671 (9.9%) | 868 (13.2%) | 225 (12.1%) | < 0.001 |
 Studying full-time/part-time | 3112 (74.9%) | 1116 (16.5%) | 320 (4.9%) | 52 (2.8%) | < 0.001 |
 Unemployment, COVID19, retirement and other benefits | 293 (7.1%) | 661 (9.8%) | 594 (9.0%) | 139 (7.5%) | < 0.001 |
 Unpaid carer/houseworker | 134 (3.2%) | 341 (5.0%) | 448 (6.8%) | 97 (5.2%) | < 0.001 |
Completed education | Â | Â | Â | Â | Â |
 Primary education | 40 (1.0%) | 29 (0.4%) | 93 (1.4%) | 52 (2.8%) | < 0.001 |
 Secondary education | 2377 (57.3%) | 1264 (18.7%) | 1333 (20.3%) | 476 (25.6%) |  |
 University education | 1733 (41.8%) | 5450 (80.8%) | 5149 (78.3%) | 1332 (71.6%) |  |
Caregiver | Â | Â | Â | Â | Â |
 No | 3987 (96.8%) | 5416 (80.7%) | 2520 (38.4%) | 541 (29.1%) | < 0.001 |
 Yes | 130 (3.2%) | 1295 (19.3%) | 4048 (61.6%) | 1316 (70.9%) |  |
Financial problems < 12 months |  |  |  |  |  |
 Always/Many times | 505 (12.8%) | 978 (14.7%) | 611 (9.4%) | 151 (8.2%) | < 0.001 |
 Some/A few times | 1399 (35.6%) | 2164 (32.4%) | 1820 (27.9%) | 495 (26.9%) |  |
 Never | 2029 (51.6%) | 3533 (52.9%) | 4090 (62.7%) | 1195 (64.9%) |  |
Self-rated health | Â | Â | Â | Â | Â |
 Excellent | 289 (7.0%) | 470 (7.0%) | 393 (6.0%) | 110 (5.9%) | < 0.001 |
 Very good | 1661 (40.4%) | 2789 (41.4%) | 2387 (36.3%) | 593 (31.9%) |  |
 Good | 1789 (43.5%) | 2948 (43.7%) | 3188 (48.5%) | 940 (50.6%) |  |
 Fair | 374 (9.1%) | 492 (7.3%) | 550 (8.4%) | 187 (10.1%) |  |
 Poor | 29 (0.7%) | 42 (0.6%) | 55 (0.8%) | 27 (1.5%) |  |
Age at menarche [M (SD)] | 12.2 (1.4) | 12.3 (1.5) | 12.5 (1.5) | 12.6 (1.6) | < 0.001 |
 ≤10 | 372 (9.2%) | 540 (8.1%) | 460 (7.1%) | 119 (6.5%) | < 0.001 |
 11–12 | 2092 (51.7%) | 3299 (49.5%) | 2980 (45.7%) | 753 (40.9%) |  |
 13–15 | 1507 (37.2%) | 2660 (40.0%) | 2894 (44.4%) | 895 (48.6%) |  |
 ≥16 | 78 (1.9%) | 159 (2.4%) | 188 (2.9%) | 74 (4.0%) |  |
Menstrual bleeding abundance | Â | Â | Â | Â | Â |
 < 25 ml | 664 (16.0%) | 1198 (17.7%) | 1103 (16.7%) | 370 (19.9%) | 0.001 |
 25–80 ml | 2822 (67.9%) | 4370 (64.7%) | 3894 (59.1%) | 988 (53.0%) | < 0.001 |
 > 80 ml | 736 (17.7%) | 1233 (18.3%) | 1513 (23.0%) | 441 (23.7%) | < 0.001 |
Menstrual blood clots | Â | Â | Â | Â | Â |
 No | 2585 (62.2%) | 4293 (63.6%) | 4284 (65.0%) | 1239 (66.5%) | 0.002 |
 Yes | 1570 (37.8%) | 2460 (36.4%) | 2303 (35.0%) | 624 (33.5%) |  |
Menstrual bleeding duration | Â | Â | Â | Â | Â |
 < 2 days | 33 (0.8%) | 98 (1.5%) | 129 (2.0%) | 56 (3.0%) | < 0.001 |
 2–7 days | 3820 (92.1%) | 6252 (92.7%) | 6061 (92.1%) | 1632 (88.2%) |  |
 > 7 days | 294 (7.1%) | 395 (5.9%) | 388 (5.9%) | 162 (8.8%) |  |
Menstrual cycle duration | Â | Â | Â | Â | Â |
 < 21 days | 311 (7.7%) | 437 (6.6%) | 588 (9.0%) | 191 (10.6%) | < 0.001 |
 21–35 days | 3158 (78.1%) | 5534 (83.1%) | 5686 (86.8%) | 1451 (80.2%) |  |
 > 35 days | 574 (14.2%) | 690 (10.4%) | 275 (4.2%) | 168 (9.3%) |  |
Menstrual pain | Â | Â | Â | Â | Â |
 Low intensity (1–3) | 733 (18.1%) | 1677 (25.3%) | 2574 (39.8%) | 890 (48.8%) | < 0.001 |
 Moderate intensity (4–7) | 2102 (51.8%) | 3245 (49.0%) | 2784 (43.0%) | 661 (36.2%) |  |
 High intensity (8–10) | 1224 (30.2%) | 1700 (25.7%) | 1111 (17.2%) | 273 (15.0%) |  |
Menstrual pain management | Â | Â | Â | Â | Â |
 Use of analgesics | 3079 (75.9%) | 4607 (69.6%) | 4167 (64.4%) | 1125 (61.6%) | < 0.001 |
 Use of natural remedies | 2458 (60.6%) | 3999 (60.4%) | 2861 (44.2%) | 568 (31.1%) | < 0.001 |
 Yoga/Meditation or physical activity | 24 (0.6%) | 71 (1.1%) | 55 (0.8%) | 10 (0.5%) | 0.027 |
 Resting, self-care (including through nutrition) | 34 (0.8%) | 97 (1.5%) | 141 (2.2%) | 24 (1.5%) | < 0.001 |
 Sex (including masturbation) | 8 (0.2%) | 30 (0.5%) | 19 (0.3%) | 2 (0.1%) | 0.037 |
 Cannabis, cannabidiol (CBD), or alcohol use | 6 (0.1%) | 24 (0.4%) | 13 (0.2%) | 1 (0.1%) | 0.031 |
 Alternative medicine | 2 (0.0%) | 19 (0.3%) | 20 (0.3%) | 3 (0.2%) | 0.033 |
 Accessing the emergency room | 6 (0.1%) | 4 (0.1%) | 2 (0.0%) | 2 (0.1%) | 0.164 |
 Physiotherapy/Osteotherapy | 1 (0.0%) | 5 (0.1%) | 9 (0.1%) | 1 (0.1%) | 0.234 |
 Transcutaneous electric stimulation | 1 (0.0%) | 4 (0.1%) | 2 (0.0%) | 0 (0.0%) | 0.595 |
 Cannot afford menstrual pain management products | 17 (0.4%) | 13 (0.2%) | 7 (0.1%) | 3 (0.2%) | 0.008 |
 I do not do anything | 823 (20.3%) | 1176 (17.8%) | 1342 (20.7%) | 378 (20.7%) | < 0.001 |
 I experience no menstrual pain | 218 (5.4%) | 422 (6.4%) | 642 (9.9%) | 238 (13.0%) | < 0.001 |
 I do not know what to do | 200 (4.9%) | 227 (3.4%) | 88 (1.4%) | 11 (0.6%) | < 0.001 |
Premenstrual symptoms | Â | Â | Â | Â | Â |
 Always/Many times | 2552 (68.2%) | 4331 (70.5%) | 4068 (67.7%) | 1058 (61.9%) | < 0.001 |
 Some/A few times | 1011 (27.0%) | 1562 (25.4%) | 1641 (27.3%) | 537 (31.4%) |  |
 Never | 179 (4.8%) | 250 (4.1%) | 302 (5.0%) | 113 (6.6%) |  |
Gynecological and systemic health conditions | Â | Â | Â | Â | Â |
 Anemia | 987 (23.8%) | 2047 (30.3%) | 2287 (34.7%) | 637 (34.2%) | < 0.001 |
 Iron deficiency | 1413 (34.0%) | 2860 (42.4%) | 3355 (50.9%) | 973 (52.2%) | < 0.001 |
 Uterine myomas | 17 (0.4%) | 234 (3.5%) | 786 (11.9%) | 417 (22.4%) | < 0.001 |
 Endometrial polyps | 43 (1.0%) | 222 (3.3%) | 502 (7.6%) | 222 (11.9%) | < 0.001 |
 Endometriosis/adenomyosis | 60 (1.4%) | 307 (4.5%) | 421 (6.4%) | 137 (7.4%) | < 0.001 |
 Polycystic ovary syndrome | 464 (11.2%) | 1312 (19.4%) | 1089 (16.5%) | 207 (11.1%) | < 0.001 |
 Premenstrual syndrome/dysphoric premenstrual disorder | 410 (9.9%) | 952 (14.1%) | 971 (14.7%) | 296 (15.9%) | < 0.001 |
 Gynaecological cancers (ovary or fallopian tube, urine and cervical) | 2 (0.0%) | 37 (0.5%) | 54 (0.8%) | 14 (0.8%) | < 0.001 |
 Breast cancer | 1 (0.0%) | 6 (0.1%) | 36 (0.5%) | 31 (1.7%) | < 0.001 |
 No diagnosis | 1846 (44.4%) | 1983 (29.4%) | 1463 (22.2%) | 412 (22.1%) | < 0.001 |